Exxonmobil Investment Management Inc. TX decreased its position in Agilent Technologies Inc (NYSE:A) by 12.8% during the fourth quarter, HoldingsChannel reports. The firm owned 51,172 shares of the medical research company’s stock after selling 7,509 shares during the quarter. Exxonmobil Investment Management Inc. TX’s holdings in Agilent Technologies were worth $3,427,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Parametric Portfolio Associates LLC boosted its stake in Agilent Technologies by 9.4% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 616,303 shares of the medical research company’s stock worth $39,567,000 after purchasing an additional 52,920 shares in the last quarter. Steward Partners Investment Advisory LLC bought a new position in Agilent Technologies in the 3rd quarter worth about $213,000. Public Employees Retirement System of Ohio boosted its stake in Agilent Technologies by 0.9% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 394,744 shares of the medical research company’s stock worth $25,343,000 after purchasing an additional 3,452 shares in the last quarter. Coastline Trust Co boosted its stake in Agilent Technologies by 20.1% in the 3rd quarter. Coastline Trust Co now owns 10,280 shares of the medical research company’s stock worth $660,000 after purchasing an additional 1,720 shares in the last quarter. Finally, Hahn Capital Management LLC boosted its stake in Agilent Technologies by 1.0% in the 3rd quarter. Hahn Capital Management LLC now owns 598,781 shares of the medical research company’s stock worth $38,442,000 after purchasing an additional 5,648 shares in the last quarter.

A has been the topic of several research analyst reports. Barclays restated a “buy” rating and set a $74.00 target price on shares of Agilent Technologies in a research note on Monday, January 8th. Goldman Sachs Group restated a “neutral” rating and set a $68.00 target price on shares of Agilent Technologies in a research note on Tuesday, September 26th. Evercore ISI initiated coverage on shares of Agilent Technologies in a research note on Wednesday, January 3rd. They set an “outperform” rating and a $75.00 target price on the stock. Cowen restated a “hold” rating and set a $65.00 target price on shares of Agilent Technologies in a research note on Thursday, September 28th. Finally, Robert W. Baird restated a “buy” rating and set a $72.00 target price on shares of Agilent Technologies in a research note on Friday, November 24th. Six investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $68.98.

In related news, CEO Michael R. Mcmullen sold 22,481 shares of the stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $68.77, for a total value of $1,546,018.37. Following the completion of the sale, the chief executive officer now directly owns 336,637 shares of the company’s stock, valued at approximately $23,150,526.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Patrick Kaltenbach sold 7,358 shares of the stock in a transaction that occurred on Wednesday, November 22nd. The stock was sold at an average price of $69.28, for a total transaction of $509,762.24. Following the completion of the sale, the insider now directly owns 72,862 shares of the company’s stock, valued at $5,047,879.36. The disclosure for this sale can be found here. Insiders have sold a total of 176,291 shares of company stock valued at $12,245,920 in the last ninety days.

Shares of Agilent Technologies Inc (A) opened at $71.73 on Friday. Agilent Technologies Inc has a 52-week low of $47.05 and a 52-week high of $72.33. The company has a market cap of $22,869.67, a PE ratio of 29.87, a PEG ratio of 2.14 and a beta of 1.28. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The firm had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same quarter in the prior year, the firm earned $0.59 EPS. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. sell-side analysts expect that Agilent Technologies Inc will post 2.58 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be given a dividend of $0.149 per share. The ex-dividend date of this dividend is Friday, December 29th. This represents a $0.60 annualized dividend and a dividend yield of 0.83%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s dividend payout ratio is presently 28.57%.

COPYRIGHT VIOLATION NOTICE: This article was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://www.thecerbatgem.com/2018/01/13/exxonmobil-investment-management-inc-tx-has-3-43-million-position-in-agilent-technologies-inc-a.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Stock Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related stocks with our FREE daily email newsletter.